Regulatory Filing For FACTIVE Tablets Submitted In Europe
May 15th 2008Drug InformationPharma Industry
Oscient Pharmaceuticals Corporation’s (Nasdaq: OSCI) commercialization partner for FACTIVEŽ (gemifloxacin mesylate) tablets, Menarini Group, a leading European pharmaceutical company based in Italy, has submitted a regulatory filing seeking approval of FACTIVE in Europe.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
